Title : Efficiency of low dosage apatinib in post-first-line treatment of advanced lung adenocarcinoma.

Pub. Date : 2017 Sep 12

PMID : 29029508






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In this study, we showed the results of apatinib as second-line to fourth-line treatment in EGFR wild-type advanced lung adenocarcinoma patients. apatinib epidermal growth factor receptor Homo sapiens
2 16 EGFR wild-type advanced lung adenocarcinoma patients were administrated apatinib (250-500 mg/d) orally. apatinib epidermal growth factor receptor Homo sapiens
3 So, apatinib might be an optional choice for post-first-line treatment of EGFR wild-type advanced lung adenocarcinoma patients. apatinib epidermal growth factor receptor Homo sapiens